ClinicalTrials.gov
public full text
Public Domain
A Study of LY3050258 in Healthy Participants
The main purpose of this study is to evaluate the safety and how well the body will handle a single dose of increasing strength of study drug LY3050258. Each participant will receive LY3050258 or placebo once, in each of 2 dosing periods. At least 7 days will pass between doses. This study will last approximately 45 days for each participant. Screening is required within 28 days before the start of the study.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol#1045211
- A Study of LY3127760 in Healthy Participants#877420
- A Study of LY3079514 in Healthy Participants#888679
- A Multiple Dose Study of LY3023703 in Healthy Participants#885614
- A Study of LY3463251 in Healthy Participants#906560
Record · ID 1371564
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive